Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 6
2020 9
2021 6
2022 4
2023 2
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Immunometabolism and autoimmunity.
Galgani M, Bruzzaniti S, Matarese G. Galgani M, et al. Among authors: bruzzaniti s. Curr Opin Immunol. 2020 Dec;67:10-17. doi: 10.1016/j.coi.2020.07.002. Epub 2020 Aug 9. Curr Opin Immunol. 2020. PMID: 32784085 Review.
Metabolism and Autoimmune Responses: The microRNA Connection.
Colamatteo A, Micillo T, Bruzzaniti S, Fusco C, Garavelli S, De Rosa V, Galgani M, Spagnuolo MI, Di Rella F, Puca AA, de Candia P, Matarese G. Colamatteo A, et al. Among authors: bruzzaniti s. Front Immunol. 2019 Aug 28;10:1969. doi: 10.3389/fimmu.2019.01969. eCollection 2019. Front Immunol. 2019. PMID: 31555261 Free PMC article. Review.
Metabolomics, Lipidomics, and Immunometabolism.
Carbone F, Bruzzaniti S, Fusco C, Colamatteo A, Micillo T, De Candia P, Bonacina F, Norata GD, Matarese G. Carbone F, et al. Among authors: bruzzaniti s. Methods Mol Biol. 2021;2285:319-328. doi: 10.1007/978-1-0716-1311-5_24. Methods Mol Biol. 2021. PMID: 33928562
Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes.
Strollo R, Vinci C, Man YKS, Bruzzaniti S, Piemonte E, Alhamar G, Briganti SI, Malandrucco I, Tramontana F, Fanali C, Garnett J, Buccafusca R, Guyer P, Mamula M, James EA, Pozzilli P, Ludvigsson J, Winyard PG, Galgani M, Nissim A. Strollo R, et al. Among authors: bruzzaniti s. Diabetologia. 2023 Jan;66(1):132-146. doi: 10.1007/s00125-022-05812-4. Epub 2022 Oct 7. Diabetologia. 2023. PMID: 36207582 Free PMC article.
Immunometabolism of regulatory T cells in cancer.
Galgani M, Bruzzaniti S, La Rocca C, Micillo T, de Candia P, Bifulco M, Matarese G. Galgani M, et al. Among authors: bruzzaniti s. Mol Aspects Med. 2021 Feb;77:100936. doi: 10.1016/j.mam.2020.100936. Epub 2020 Nov 26. Mol Aspects Med. 2021. PMID: 33250195
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis.
De Vito F, Musella A, Fresegna D, Rizzo FR, Gentile A, Stampanoni Bassi M, Gilio L, Buttari F, Procaccini C, Colamatteo A, Bullitta S, Guadalupi L, Caioli S, Vanni V, Balletta S, Sanna K, Bruno A, Dolcetti E, Furlan R, Finardi A, Licursi V, Drulovic J, Pekmezovic T, Fusco C, Bruzzaniti S, Hornstein E, Uccelli A, Salvetti M, Matarese G, Centonze D, Mandolesi G. De Vito F, et al. Among authors: bruzzaniti s. Neuropathol Appl Neurobiol. 2022 Feb;48(2):e12765. doi: 10.1111/nan.12765. Epub 2021 Oct 6. Neuropathol Appl Neurobiol. 2022. PMID: 34490928 Free PMC article.
Type 2 Diabetes: How Much of an Autoimmune Disease?
de Candia P, Prattichizzo F, Garavelli S, De Rosa V, Galgani M, Di Rella F, Spagnuolo MI, Colamatteo A, Fusco C, Micillo T, Bruzzaniti S, Ceriello A, Puca AA, Matarese G. de Candia P, et al. Among authors: bruzzaniti s. Front Endocrinol (Lausanne). 2019 Jul 4;10:451. doi: 10.3389/fendo.2019.00451. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31333589 Free PMC article.
27 results